Plain-English translation of NCT07260877 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help treat cutaneous lupus erythematosus — a form of lupus that affects the skin. Researchers want to find out whether this medication reduces the activity and severity of skin symptoms and what side effects people might experience. The study will compare the medication to a placebo (an inactive look-alike) to see if actually works.
Cutaneous lupus can cause painful and visible skin lesions that significantly affect quality of life, and current treatment options may not work well enough for everyone. This trial aims to find out whether this medication could offer a new, more effective treatment option for people living with this condition.
You likely qualify if…
You likely don't qualify if…
You would take either or a placebo for the first 4 weeks, then switch to for another 8 weeks — neither you nor the researchers will know which you received first. You'll visit the clinic once a month for checkups and tests to see how your skin is responding and to monitor for any side effects. In total, the study lasts about 3 months.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States